← Leaderboards
Steven C Ghivizzani
Brigham And Women'S Hospital
$7,278,988
Attributed
$7,278,988
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$7,278,988 · 6
By mechanism
R01$6,852,700 · 3
R03$254,250 · 1
R41$142,038 · 1
R13$30,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Daniel Hal Solomon$26,002,677
- Jeffrey W Duryea$3,709,413
- Jeffrey Neil Katz$23,923,428
- Shuichi Mizuno$79,390
- Alicia L Bertone$717,561
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyArthritisJointsGenesGene Delivery SystemClinical ApplicationGene ExpressionBiologicalGene DeliveryDesignVectorRheumatoid ArthritisMediatingAffectTransgenic OrganismsResearch StudyBasePhenotypeGene TransferTransfection /Expression VectorBiotechnologyTissue /Cell CultureKneeLaboratory Rabbit
Grant awards (28)
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia$310,111
R01 · FY2014 · AR · contact PI
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia$300,618
R01 · FY2013 · AR · contact PI
Utility of AAV serotypes for gene delivery in treatment of chronic joint disease$292,252
R01 · FY2013 · AR · contact PI
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia$316,440
R01 · FY2012 · AR · contact PI
Utility of AAV serotypes for gene delivery in treatment of chronic joint disease$308,370
R01 · FY2012 · AR · contact PI
Utility of AAV Serotypes for Gene Delivery in Treatment of Chronic Joint Disease$862,998
R01 · FY2011 · AR · contact PI
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia$316,440
R01 · FY2011 · AR · contact PI
Utility of AAV serotypes for gene delivery in treatment of chronic joint disease$309,009
R01 · FY2011 · AR · contact PI
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia$329,625
R01 · FY2010 · AR · contact PI
Utility of AAV serotypes for gene delivery in treatment of chronic joint disease$322,465
R01 · FY2010 · AR · contact PI
Utility of AAV serotypes for gene delivery in treatment of chronic joint disease$326,231
R01 · FY2009 · AR · contact PI
5th international meeting of gene and cell therapies for arthritis and related di$20,000
R13 · FY2008 · AR · contact PI
Gene Delivery to Cartilage Defects via Marrow Coagulates$298,339
R01 · FY2007 · AR · contact PI
5th international meeting of gene and cell therapies for arthritis and related di$10,000
R13 · FY2007 · AR · contact PI
Gene Delivery to Cartilage Defects via Marrow Coagulates$307,249
R01 · FY2006 · AR · contact PI
Persistence of Transgene Expression in Synovium$262,139
R01 · FY2006 · AR · contact PI
Gene Delivery to Cartilage Defects via Marrow Coagulates$341,925
R01 · FY2005 · AR
Persistence of Transgene Expression in Synovium$307,733
R01 · FY2005 · AR
Gene Delivery to Cartilage Defects via Marrow Coagulates$330,716
R01 · FY2004 · AR
Persistence of Transgene Expression in Synovium$292,718
R01 · FY2004 · AR
Persistence of Transgene Expression in Synovium$236,242
R01 · FY2003 · AR
Gene Delivery to Cartilage Defects via Marrow Coagulates$189,426
R01 · FY2003 · AR
Gene Delivery to Cartilage Defects via Marrow Coagulates$182,610
R01 · FY2003 · AR
Gene Therapy for Arthritis Using Lentiviral Vectors$142,038
R41 · FY2003 · AR
Persistence of Transgene Expression in Synovium$109,044
R01 · FY2003 · AR
Intra-articular Gene Transfer and Expression of sCD4$84,750
R03 · FY2003 · AR
Intra-articular Gene Transfer and Expression of sCD4$84,750
R03 · FY2002 · AR
Intra-articular Gene Transfer and Expression of sCD4$84,750
R03 · FY2001 · AR